KLAS ranks MedPlus top DMI vendor in 2006

27 August 2006

The USA's Quest Diagnostics says that its MedPlus health care information technology subsidiary has been recognized as the number one document management and imaging vendor in the 2006 Top 20 KLAS Mid-Year Report Card. This top position marks the fourth time the company's ChartMaxx product, an enterprise-wide electronic health record solution, has come first in the mid-year report.

KLAS, a research and consulting firm specializing in the health care industry, based the rankings on interviews with industry executives, professionals and clinicians at more than 4,500 hospitals and 2,500 clinics nationwide. The ratings, which are derived from current customers' feedback, found that ChartMaxx was ranked the tenth best solution out of 96 products for its ability to provide an immediate operational impact to hospitals, while 100% of MedPlus customer respondents indicated they would buy ChartMaxx again.

KLAS defines DMI products as those that provide the core capabilities of scanning, creating, archiving, workflow and validation of electronically stored documents and images (not clinical images).

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight